Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.
Tomioka N, Oba S, Ohira M, Misra A, Fridlyand J, Ishii S, Nakamura Y, Isogai E, Hirata T, Yoshida Y, Todo S, Kaneko Y, Albertson DG, Pinkel D, Feuerstein BG, Nakagawara A.
Tomioka N, et al. Among authors: todo s.
Oncogene. 2008 Jan 17;27(4):441-9. doi: 10.1038/sj.onc.1210661. Epub 2007 Jul 16.
Oncogene. 2008.
PMID: 17637744